SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-023151
Filing Date
2024-04-30
Accepted
2024-04-29 17:54:46
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-30

Document Format Files

Seq Description Document Type Size
1 ARS ny20023585x2_ars.pdf ARS 1587718
  Complete submission text file 0001140361-24-023151.txt   2188390
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33958 | Film No.: 24893172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)